$AIM 8-K SEC Filings

Filed On	Filing
14 Sep 2026	8-K: Entry into a Material Definitive Agreement; Unregistered Sales of Equity Securities From September 8, 2026 to September 9, 2026, AIM ImmunoTech Inc. (the “Company”) entered into a total of two exchange agreements (the “Exchange Agreements”) and, for each, a corresponding partitioned promissory note (together, the “Parti...
10 Sep 2026	8-K: Entry into a Material Definitive Agreement; Unregistered Sales of Equity Securities THE EXCHANGE CONTEMPLATED HEREIN IS INTENDED TO COMPORT WITH THE REQUIREMENTS OF SECTION 3(a)(9) OF THE SECURITIES ACT OF 1933, AS AMENDED.
04 Sep 2026	8-K: Entry into a Material Definitive Agreement; Termination of a Material Definitive Agreement +1 more
11 Aug 2026	8-K: Regulation FD Disclosure
10 Aug 2026	8-K: Results of Operations and Financial Condition
06 Aug 2026	8-K: Entry into a Material Definitive Agreement; Shareholder Director Nominations
05 Aug 2026	8-K: Termination of a Material Definitive Agreement
16 Jul 2026	8-K: Submission of Matters to a Vote of Security Holders
15 Jun 2026	8-K: Other Events
11 Jun 2026	8-K: Entry into a Material Definitive Agreement; Unregistered Sales of Equity Securities +1 more
10 Jun 2026	8-K: Amendments to Articles/Bylaws; Change in Fiscal Year
04 Jun 2026	8-K: Regulation FD Disclosure
21 May 2026	8-K: Entry into a Material Definitive Agreement; Unregistered Sales of Equity Securities +1 more
19 May 2026	8-K: Entry into a Material Definitive Agreement; Results of Operations and Financial Condition +2 more
14 May 2026	8-K: Regulation FD Disclosure
12 May 2026	8-K: Unregistered Sales of Equity Securities
08 May 2026	8-K: Entry into a Material Definitive Agreement; Unregistered Sales of Equity Securities
10 Apr 2026	8-K: Entry into a Material Definitive Agreement
06 Mar 2026	8-K: Entry into a Material Definitive Agreement; Material Modification to Rights of Security Holders +2 more
05 Feb 2026	8-K: Regulation FD Disclosure; Other Events

Comments